MFG Tray Recognizes Distributor
MFG Tray names ChemTech International as its first Master Pharmaceutical Distributor.
Molded Fiber Glass Tray (MFG Tray) has selected ChemTech International as its master pharmaceutical distributor because of ChemTech’s market growth success and the longtime relationship with MFG Tray, according to a MFG Tray press release. The designation, the first offered by MFG Tray, means the ChemTech team is a trusted and valued partner and broadens ChemTech’s opportunities and responsibilities with MFG Tray.
The pharmaceutical line of products manufactured by MFG Tray are used worldwide in the pharmaceutical, nutraceutical, biotech, vaccine, lyophilization, and veterinary science markets. Since 1992, ChemTech has exported and distributed MFG Tray’s pharmaceutical products to destinations including the European Union, South Africa, Southeast Asia, India, South America, and Australia.
Source: Molded Fiber Glass Tray
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
Cosette Pharmaceuticals Adds to Dermatology and Women’s Health Portfolio with Mayne Pharma Purchase
Published: February 26th 2025 | Updated: February 26th 2025While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of the acquisition.
FDA Approves First Treatment for Rare Lipid Storage Disease Cerebrotendinous Xanthomatosis
February 24th 2025Cerebrotendinous xanthomatosis, or CTX, is a metabolic disorder caused by a gene mutation that results in a deficiency of an important enzyme in the ability of the human body to break down fats.
